18 research outputs found
《理科》科学的に探究し問いつづける生徒の育成 : 深い学びを引き起こすアクティブ・ラーニングを通して
<p>(B1 inflammatory, B2 stricturing, B3 penetrating, B23 stricturing and penetrating).</p
Identification of Internal Penetrating or Stricturing Complications.
<p>Identification of Internal Penetrating or Stricturing Complications.</p
Rolling phenotype (B1 inflammatory, B2 stricturing, B3 penetrating, B23 stricturing and penetrating).
<p>Rolling phenotype (B1 inflammatory, B2 stricturing, B3 penetrating, B23 stricturing and penetrating).</p
Rolling phenotype, only patients with B23 phenotype within one year of diagnosis.
<p>(B1 inflammatory, B2 stricturing, B3 penetrating, B23 stricturing and penetrating).</p
Cumulative Montreal phenotype (B1 inflammatory, B2 stricturing, B3 penetrating).
<p>Cumulative Montreal phenotype (B1 inflammatory, B2 stricturing, B3 penetrating).</p
Treatments.
<p>m: month. AZA: azathiopurin. 6MP: 6 mercaptopurin. clinical response (+ or-) / mucosal effect (+/-)</p><p>Treatments.</p
Phenotype of lamina propria intestinal lymphocytes.
<p>Phenotype of lamina propria intestinal lymphocytes.</p
Phenotype of peripheral blood lymphocytes.
<p>Phenotype of peripheral blood lymphocytes.</p
H&E staining of the duodenal biopsies of one patient treated with Olmesartan (patient 2) (A, B) and of one patient with AIE (patient 7) (C, D) showing subtotal villous atrophy (A, C: original magnification x 100) with glandular apoptosis (B, D: original magnification x200).
<p>H&E staining of the duodenal biopsies of one patient treated with Olmesartan (patient 2) (A, B) and of one patient with AIE (patient 7) (C, D) showing subtotal villous atrophy (A, C: original magnification x 100) with glandular apoptosis (B, D: original magnification x200).</p